 |
Ms. Eden Mariam Jacob (April 2018 - )( Title of the work: Biocompatible Nanoparticles for the Treatment of Inflammatory Bowel Disease )Doctoral Student Bio Nano- Electronics Research Centre Graduate School of Interdisciplinary New Science β-Building, Toyo University, Kawagoe,Saitama, Japan |
Academic Profile:
- Ph.D. Bio- nanotechnology (Pursuing Since April 2018-)
- Master of Science (MSc) Food Science & Nutrition (2015-2017)
- Bachelor of Science (BSc) Nutrition & Dietetics (2012-2015)
Professional History:
- Research Assistant at Bio Nano Electronics Research Centre, Toyo University, Japan (May 2018-)
- Teachers assistant for Special English Reading -1 at Faculty of Information Science and Arts, Toyo University, Japan (May 2019- July 2019)
- Research assistant at Bhoomi Natural Products &Exports PVT LTD, Cochin, India (May 2017- Oct 2017)
Other Acheivements
- Awarded 3rd rank in Msc Food science and Nutrition for the batch of 2015- 2017 during Tenth convocation at Mount Carmel College, Bengaluru, India (January 2019)
- Recipient of Monbukagakusho (MEXT- 2018) Japanese Government Scholarship
Research Interest:
Development of Biocompatible nanocarriers for the oral delivery of drug for the Inflammatory Bowel Disease.
Addressing the physiological changes in the disease with more promising results through selective drug delivery to the inflamed intestines.
- Effective targeting
- Increased bioavailability
- Reduced systemic effects
Poster Presentation:
- Eden Mariam Jacob, M. Sheikh Mohamed, T. Maekawa, D. Sakthi Kumar. Biocompatible Nanoparticles for the Treatment of Inflammatory Bowel Disease. 16th International Symposium on Bioscience and Nanotechnology. BNERC, Toyo University, 2018.
- Eden Mariam Jacob, Sangeeta Pandey. Sensory Evaluation and Nutrient Composition of Crackers Made from Quinoa (Chenopodium quinoa) and Pumpkin Seeds (Cucurbita pepo). National Conference on food-based approaches for Translational nutrition organized by Nutrition society of India organized by Mysore chapter on 12 and 13 April 2017.
Thesis Outline:
Inflammatory bowel diseases (IBD) are chronic, relapsing, remitting autoimmune diseases affecting the gastro intestinal (GI) tract. IBD has become a Global disease of the 21st century affecting nearly 5 million people worldwide, with almost $ 6 billion spent (2017) on treatments and occurs most often in patients aged 15 to 30 years. Two known forms of IBD are Crohn's disease (CD) and Ulcerative colitis (UC). There is currently no cure for IBD, the therapeutic strategies are aimed at maintaining remission from inflammatory responses. Steroids are commonly prescribed for exacerbation of both CD and UC but prolonged use can lead to undesirable systemic side- effects. Therefore development of biocompatible nanocarriers through oral drug delivery system can improve the bioavailability of the drug and do not produce any systemic toxicity
